Navigation Links
invivodata Recognized as One of Pittsburgh's Fastest Growing Private Companies
Date:9/1/2009

PITTSBURGH, Sept. 1 /PRNewswire/ -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that the company has been recognized in the "2009 Pittsburgh 100" annual ranking of the fastest-growing, privately-held companies in Western Pennsylvania by the Pittsburgh Business Times.

"We see the Pittsburgh 100 as one of the most important lists we publish," said Alan Robertson, publisher of the Pittsburgh Business Times. "The companies on this list represent many industries and many geographic locations around the region. The Pittsburgh 100 companies also represent all different sizes of companies, from small firms to multi-billion dollar operations. The Pittsburgh 100 is proof that the region remains a vibrant, growth-oriented business environment."

invivodata was named to the annual Pittsburgh 100 based on its revenue growth rate from 2006 through 2008. Honored at an awards program at the Duquesne Club in downtown Pittsburgh on August 27, invivodata was ranked the 16th fastest-growing technology company and #87 overall on the list of 100, based on revenue growth.

"We are a proud member of the Pittsburgh business community and are very pleased to once again be included on this list," said Doug Engfer, invivodata president and CEO. "We believe our steady growth stems from our commitment to delivering value with our practical and reliable solutions and services that help pharmaceutical companies collect better data and run more efficient clinical trials."

In the past year, invivodata has led the industry in developing innovative patient and site based ePRO solutions to meet the evolving needs of global clinical trial sponsors. Strong growth in its scientific and regulatory consulting division, PRO Consulting(TM), coupled with expanded partnerships with Contract Research Organizations and integrations with market-leading eClinical systems has enabled the organization to continue delivering consistent results to new and existing customers.

For additional information on invivodata's solutions and services, visit www.invivodata.com.

About invivodata inc.

invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata's solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata's solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.

    For more information, contact:

    invivodata inc.
    Christine Tobin
    Corporate Communications Specialist
    (412) 390-3000, ext. 3502
    ctobin@invivodata.com


'/>"/>
SOURCE invivodata inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. invivodata Captures Symptom Relief Data in Endometriosis Trial
2. invivodata Certified to Deliver EXACT in COPD Trials
3. FreshFx Recognized for use in the Scalder as a Solution to the Yield/Pathogen Reduction Dilemma
4. Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09
5. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
6. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
7. Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
8. NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
9. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
10. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
11. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... to 2025" report to their offering. ... The Global Cryostat Market is poised ... decade to reach approximately $3.5 billion by 2025. This ... given segments on global as well as regional levels presented in ...
(Date:3/23/2017)... 2017 The key factors driving the ... population, accelerating economic growth and increasing healthcare expenditure. Some of ... life expectancy of ESRD patients, rising demand for home PD ... expansion of the market is hindered by high treatment costs ... ...
(Date:3/23/2017)... 23, 2017  Transportation Insight, a multi-modal lead logistics ... chain management firm with expertise serving clients in the ... Rick Zaffarano was named a 2017 Food ... by the only publication exclusively dedicated to covering the ... "Rick has brought to Transportation Insight a ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the ... medical professionals caring for those suffering from the full spectrum of disordered eating, announced ... eating disorders professionals from nearly all 50 states and several countries converged on the ...
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge ... offering treatments for sleep apnea and TMJ at their office. TMJ, or temporomandibular ... specifically the obstructive type, is increasingly being treated at dental offices with newly ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in Southlake, ... leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” ... designed to teach how to maximize their sales efforts, as well as how ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of ... people of God in congregations across the United States. “The Communion of ... in 1964 who has served congregations in seven states throughout his long career ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... services to their communities, 16 more public health departments have been awarded national ... bring another 4.5 million people into the expanding network of communities across the ...
Breaking Medicine News(10 mins):